Dr. Ana Weil studies the relationship between the gut microbiome and immune responses to enteric diseases. Using molecular, genomic and immunologic methods, she investigates how the gut microbiome influences susceptibility to enteric infections, modulation of immune responses by the gut microbiome, and pathogen-gut microbe interactions at the mucosal surface.
She works with several US-based collaborators and the International Centre for Diarrhoeal Disease Research, Bangladesh.
The Weil lab focused on understanding how the gut microbiota impacts enteric disease and immune responses to enteric infection. We primarily study Vibrio cholerae, the causative agent of cholera, using molecular tools and methods, immunoassays, anaerobic microbiology, genomics, imaging, cell culture, and small intestinal enteroid models. We aim to understand interactions between gut microbes, V. cholerae, and the host.
Dr. Weil works clinically to care for Solid Organ Transplant patients, particularly those with enteric infections.
education & training
Ana completed undergraduate studies at UC Berkeley, MPH at Johns Hopkins School of Public Health, and medical school and Tufts University. Ana completed her medical training (internal medicine residency, infectious diseases fellowship, and Chief resident year) at Massachusetts General Hospital.
Fulbright Scholar, Malawi 2001
Fogarty/NIH Clinical Scholar, International Center for Diarrheal Disease Research, Bangaldesh 2007
William Damesheck Research Award, Tufts Medical School 2010
Edward H. Kass Award for Excellence in Research, Infectious Disease Society of America 2012
ID Week Abstract Committee Choice Award, ID Week Program Committee 2015
Morton N. Swartz Professional Development Award, Division of Infectious Diseases, MGH 2018
Chief of Medicine Award, University of Washington 2021